GLP-1s may also support healthy blood sugar regulation
It will be interesting to see longer-term data to see the final plateau of weight loss. She adds that, given the minimal data so far from the company, Amgen is sort of a wild card, as it could either be best-in-class or encounter issues with tolerability or safety that make it less compelling. In the first quarter, Amgens sales grew 22%, raising its fair value estimate to $317
A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 19902010: a systematic analysis for the global burden of disease study 2010
Prescription is not guaranteed: Independent clinicians determine appropriateness based on individual health factors
Ha n is gondolkodik ezen a lehetsgen, rdemes mlyebben megrteni, hogyan mkdnek ezek a ksztmnyek, s milyen tnyezk befolysoljk a hatsukat